Westpac Banking Corp’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-13,890
Closed -$887K 906
2015
Q4
$887K Hold
13,890
0.01% 592
2015
Q3
$931K Hold
13,890
0.01% 532
2015
Q2
$949K Sell
13,890
-24,800
-64% -$1.57M 0.01% 491
2015
Q1
$2.15M Hold
38,690
0.02% 496
2014
Q4
$1.98M Sell
38,690
-27,792
-42% -$1.36M 0.02% 504
2014
Q3
$2.45M Buy
66,482
+3,902
+6% +$141K 0.02% 462
2014
Q2
$2.45M Sell
62,580
-14,400
-19% -$534K 0.02% 475
2014
Q1
$2.9M Hold
76,980
0.03% 417
2013
Q4
$2.91M Hold
76,980
0.03% 419
2013
Q3
$3.34M Buy
76,980
+16,000
+26% +$642K 0.04% 355
2013
Q2
$1.47M Buy
+60,980
New +$1.85M 0.02% 472

Other funds holding USNA

Westpac Banking Corp's USNA Position: Q1 2016 in Review

Westpac Banking Corp sold out of Usana Health Sciences (USNA) in Q1 2016, closing a stake of 13,890 shares — an estimated $887K sold.

Westpac Banking Corp first reported a position in USNA in Q2 2013 and held it in 11 quarters. The position peaked at $3.34M in Q3 2013. 136 funds tracked by Wall St. Rank hold USNA as of Q1 2016.

  • Westpac Banking Corp reported no remaining Usana Health Sciences position as of Q1 2016 after selling out during the quarter.
  • Westpac Banking Corp sold 13,890 Usana Health Sciences shares in Q1 2016, an estimated $887K.
  • Westpac Banking Corp first reported a position in Usana Health Sciences in Q2 2013 and held it in 11 quarters.
  • Westpac Banking Corp's Usana Health Sciences position peaked at $3.34M in Q3 2013.
  • 136 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2016.

Based on Westpac Banking Corp's 13F filing for Q1 2016, filed 13 May 2016.